Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sayed Gamal Matar, M.B.,B.Ch.

Concepts (21)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sayed Matar's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sayed Matar has written about over time.
Oncogenes, 1 publications between 2023 and 2023, average publication date January 2023. Epigenomics, 2 publications between 2023 and 2024, average publication date September 2023. Forkhead Transcription Factors, 2 publications between 2023 and 2024, average publication date October 2023. Kidney Neoplasms, 4 publications between 2023 and 2024, average publication date November 2023. Carcinoma, Renal Cell, 5 publications between 2023 and 2024, average publication date November 2023. T-Lymphocytes, Regulatory, 1 publications between 2024 and 2024, average publication date February 2024. Epigenesis, Genetic, 1 publications between 2024 and 2024, average publication date June 2024. Proto-Oncogene Proteins c-fos, 1 publications between 2024 and 2024, average publication date June 2024. CD8-Positive T-Lymphocytes, 1 publications between 2024 and 2024, average publication date July 2024. Immunotherapy, Adoptive, 1 publications between 2024 and 2024, average publication date July 2024. Lymphocytes, Tumor-Infiltrating, 1 publications between 2024 and 2024, average publication date July 2024. Tumor Microenvironment, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Matar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (21)
Explore
_
Co-Authors (29)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.